Bo Mollstam

This inventor holds 26 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 1 EPO patent, primarily in Lactic Acid Bacteria. Top assignees: Biogaia Ab, Biogala Ab, Biogaia Biologics Ab. Active years: 1996-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bo Mollstam. Retrieved from https://idiyas.com/inventor/bo-mollstam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 26 (Patent Applications = 5)

% Patents Active = 80.8

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 1

Average Co-Inventor Count = 2.3

ph-index = 9

Forward Citations = 426(Granted Patents)

Location History:

Raleigh, NC (US) (2000 - 2001)
Lerum, SE (1996 - 2021)

Company Filing History:

5. 3 out of 834,601

Other

patents

Years Active: 1996-2025

Loading Chart...

Areas of Expertise:

Lactic Acid Bacteria

Allergy Treatment

Infantile Colic

Dental Caries

Bacterial Strains

Food Lysine Absorption

Breast Milk Feeding

Vaccine Delivery Vehicle

Two-Compartment Container

Poultry Infections

Stabilized Formulation

Diarrhea Treatment

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12201656 - Selection of bacterial strains useful in allergy treatment (2025-01-21),

2. 11135255 - Selection of bacterial strains useful in allergy treatment (2021-10-05),

3. 9340840 - Use of selected lactic acid bacteria for reducing infantile colic (2016-05-17),

4. 9057112 - Use of selected lactic acid bacteria for reducing infantile colic (2015-06-16),

5. 8658157 - Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries (2014-02-25),

6. 8496924 - Use of lactic acid bacteria for improving food lysine absorption of pet animals (2013-07-30),

7. 8343483 - Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries (2013-01-01),

8. 8114397 - Stabilized bacterial formulation (2012-02-14),

9. 7960137 - [object Object] (2011-06-14),

10. 7955834 - Method for improved breast milk feeding to reduce the risk of allergy (2011-06-07),

11. 7910127 - Use of lactic acid bacteria for improving food lysine absorption of pet animals (2011-03-22),

12. 7678553 - [object Object] (2010-03-16),

13. 7517681 - Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries (2009-04-14),

14. 7374924 - Use of selected lactic acid bacteria for reducing infantile colic (2008-05-20),

15. 7105336 - [object Object] (2006-09-12),

Title: Innovations of Bo Mollstam in Allergy Treatment

Introduction

Bo Mollstam is an accomplished inventor based in Lerum, Sweden, known for his significant contributions to the field of allergy treatment. With an impressive portfolio of 26 patents, Mollstam has been at the forefront of developing innovative solutions aimed at improving health and wellbeing.

Latest Patents

Among his latest patents, Mollstam has made groundbreaking advancements in the selection of bacterial strains useful in allergy treatment. His innovative methodology involves screening bacterial strains for their capability of producing diacylglycerol kinase (DagK). By identifying bacterial strains capable of producing DagK, Mollstam has paved the way for effective prophylaxis, inhibition, and treatment of allergies in mammals.

Career Highlights

Throughout his career, Bo Mollstam has worked with notable companies such as BioGaia AB. His dedication to research and innovation has led to numerous advancements that address significant health challenges associated with allergies.

Collaborations

Bo Mollstam has collaborated with esteemed colleagues in his field, including Eamonn Connolly and Ivan A. Casas. These partnerships have enhanced his research efforts and contributed to the successful development of his patented technologies.

Conclusion

In summary, Bo Mollstam stands out as a prominent inventor in the realm of allergy treatment, with a strong portfolio of patents that reflect his innovative spirit and commitment to improving healthcare. His ongoing work continues to inspire advancements in medical science and allergy management.

Profile summary based on public USPTO records.